These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 24591127)
21. Rho GDP dissociation inhibitor beta promotes cell proliferation and invasion by modulating the AKT pathway in hepatocellular carcinoma. Fang Y; Yi J; Lizhi L; Qiucheng C DNA Cell Biol; 2014 Nov; 33(11):781-6. PubMed ID: 25180836 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo. Wang W; Wu F; Fang F; Tao Y; Yang L Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974 [TBL] [Abstract][Full Text] [Related]
23. [Effects of c-met-siRNA on the growth and invasion of hepatocellular carcinoma MHCC97-H cells]. Xie B; Tang DG; Dong JH Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):499-504. PubMed ID: 16867270 [TBL] [Abstract][Full Text] [Related]
24. Invasion potential of H22 hepatocarcinoma cells is increased by HMGB1-induced tumor NF-κB signaling via initiation of HSP70. Gong W; Wang ZY; Chen GX; Liu YQ; Gu XY; Liu WW Oncol Rep; 2013 Sep; 30(3):1249-56. PubMed ID: 23836405 [TBL] [Abstract][Full Text] [Related]
26. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice. Li Y; Chen L; Chan TH; Liu M; Kong KL; Qiu JL; Li Y; Yuan YF; Guan XY Gastroenterology; 2013 Jan; 144(1):179-191.e4. PubMed ID: 23022495 [TBL] [Abstract][Full Text] [Related]
27. Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma. Wu X; Chen H; Gao Q; Bai J; Wang X; Zhou J; Qiu S; Xu Y; Shi Y; Wang X; Zhou J; Fan J Mol Carcinog; 2014 Apr; 53(4):325-36. PubMed ID: 23169062 [TBL] [Abstract][Full Text] [Related]
28. Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells. Boissan M; De Wever O; Lizarraga F; Wendum D; Poincloux R; Chignard N; Desbois-Mouthon C; Dufour S; Nawrocki-Raby B; Birembaut P; Bracke M; Chavrier P; Gespach C; Lacombe ML Cancer Res; 2010 Oct; 70(19):7710-22. PubMed ID: 20841469 [TBL] [Abstract][Full Text] [Related]
29. BCA3 contributes to the malignant progression of hepatocellular carcinoma through AKT activation and NF-κB translocation. Ma D; Li M; Su J; Zhang S Exp Cell Res; 2018 Jan; 362(1):142-151. PubMed ID: 29133128 [TBL] [Abstract][Full Text] [Related]
30. Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma. Bao M; Chen Z; Xu Y; Zhao Y; Zha R; Huang S; Liu L; Chen T; Li J; Tu H; He X Liver Int; 2012 Feb; 32(2):331-8. PubMed ID: 22098666 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of CD9 expression reduces the metastatic capacity of human hepatocellular carcinoma cell line MHCC97-H. Lin Q; Peng S; Yang Y Int J Oncol; 2018 Jul; 53(1):266-274. PubMed ID: 29749468 [TBL] [Abstract][Full Text] [Related]
33. Distinct roles of Akt1 in regulating proliferation, migration and invasion in HepG2 and HCT 116 cells. Chen L; Kang QH; Chen Y; Zhang YH; Li Q; Xie SQ; Wang CJ Oncol Rep; 2014 Feb; 31(2):737-44. PubMed ID: 24297510 [TBL] [Abstract][Full Text] [Related]
34. Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells. Liu S; Li N; Yu X; Xiao X; Cheng K; Hu J; Wang J; Zhang D; Cheng S; Liu S Gastroenterology; 2013 May; 144(5):1031-1041.e10. PubMed ID: 23376424 [TBL] [Abstract][Full Text] [Related]
35. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells. Lu F; Hou YQ; Song Y; Yuan ZJ Anat Rec (Hoboken); 2013 Jan; 296(1):56-63. PubMed ID: 23125179 [TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB. Sato Y; Kato J; Takimoto R; Takada K; Kawano Y; Miyanishi K; Kobune M; Sato Y; Takayama T; Matunaga T; Niitsu Y Gut; 2006 Dec; 55(12):1801-8. PubMed ID: 16581947 [TBL] [Abstract][Full Text] [Related]
37. miR-224 promotion of cell migration and invasion by targeting Homeobox D 10 gene in human hepatocellular carcinoma. Li Q; Ding C; Chen C; Zhang Z; Xiao H; Xie F; Lei L; Chen Y; Mao B; Jiang M; Li J; Wang D; Wang G J Gastroenterol Hepatol; 2014 Apr; 29(4):835-42. PubMed ID: 24219032 [TBL] [Abstract][Full Text] [Related]
38. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma. Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295 [TBL] [Abstract][Full Text] [Related]
39. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway. Gu W; Li X; Wang J Oncol Rep; 2014 Jan; 31(1):397-404. PubMed ID: 24190507 [TBL] [Abstract][Full Text] [Related]
40. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis. Zhao J; Dong L; Lu B; Wu G; Xu D; Chen J; Li K; Tong X; Dai J; Yao S; Wu M; Guo Y Gastroenterology; 2008 Sep; 135(3):956-68. PubMed ID: 18555021 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]